BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)

57 filings reported holding BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share as of Q3 2024.
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20.7M shares of 35.9M outstanding shares and own 57.62% of the company stock.
Largest 10 shareholders include AH Capital Management, L.L.C. (3.01M shares), Sofinnova Investments, Inc. (2.3M shares), RA CAPITAL MANAGEMENT, L.P. (2.21M shares), Cormorant Asset Management, LP (1.63M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.46M shares), ORBIMED ADVISORS LLC (1.42M shares), Sands Capital Ventures, LLC (1.09M shares), ALLIANCEBERNSTEIN L.P. (994K shares), RTW INVESTMENTS, LP (786K shares), and Pivotal bioVenture Partners Investment Advisor LLC (528K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.